In this Q&A, Prof Pierce Chow of the National Cancer Centre Singapore discusses the epidemiology of liver disease in Asia Pacific; key considerations around the clinical management of common liver diseases like HBV, HCV, fatty liver and HCC; and the critical role of diagnostics in ensuring early detection and effective treatment….
Cancer Type: Liver
Liver Cancer in Japan: Dr Shun Kaneko on HCC Screening and Surveillance
Japan is a global leader in hepatocellular carcinoma (HCC) surveillance, with an effective programme that enables early-stage carcinomas detection. Yet unmet needs continue to affect the management of HCC. Learn from Dr Shun Kaneko on Japan’s progress and challenges in HCC management. …
Strengthening healthcare systems through the critical role of diagnostics
In line with the WHO Essential Diagnostics List (EDL) and Lancet Commission efforts, the Asia Pacific Medical Technology Association and its members recently came together to produce an inaugural paper about the value delivered by diagnostic technologies in the Asia Pacific region.
In this session, learn about the latest insights from public-private dialogue on improving the value recognition of diagnostic technologies by governments and payers in the region.
…
APACMed White Paper – Strengthening Healthcare Systems Through the Critical Role of Diagnostics
Diagnostic technologies are used across the entire patient journey of multiple disease states, and provide the tools to prevent, detect, and monitor the required interventions. Despite its important role, diagnostics have been historically under prioritized. Read how APACMed seeks to improve the value recognition of diagnostic solutions.
Hardesty CL, Sarno R, Pelou C, Teng G, Aslam B, Bourcet A, Nair AKR, Wang J, Lina Y, Wearne D, Panth A, Rua C, Ho R, Kumar SA, Freitas E, Charafi N, Tan V, Chen JS, Veigas V, Teo P…